Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At least 3 months
I would love to see the data that Merck is getting approval for advanced cervical cancer. At this rate we will never win this race against BP. When they have everyone in their back pocket. Advaxis better make some big friends real quick.
Barclays Global Healthcare Conference
March 13, 2018 - March 15, 2018
Didn’t realize we were attending this!!!
James and how do we know that Astra won’t try to point the finger at us. I’m sure they don’t want to take the fall for this. Even though we all know PD1 and CarT have all had problems. Looks like Petit was trying to point the finger in the webcast stating the patient was already having complications after the PD-L1 dose. Hopefully it all works out
“New Hold” Which most likely doesn’t have to do with the dose of AXAL. Until we get clarification on what caused it. This will also hurt an negotiations going on for possible partnerships. We can only hope this HOLD doesn’t get handled like the last.
Lol, everyone hoping for a deal and we get smacked in the mouth with a clinical HOLD. Nice real nice
They will not cancel the request for the additional shares.
Wow, now that’s nice to see
Looks like Aduro is the one going to be bought out
It would be nice to know that the offering was completed and successful because if they couldn’t complete the offering at a $2 pps I would take that as bad news. So YES it would be nice to know
But only one company is receiving money and the other is footing the bill. Great deals we have in place
blue, I agree!!! We have been footing most of the bill for this trial. So we should have a say on data released. My only worry is if that data is as good as they sound so excited to present it. I only hope there is a renegotiated deal before ASCO. Otherwise I fear we will only be getting data from the Advaxis arm and they will be looking for the next best combo trial. I only hope March, April and May bring us everything thing we have waited for all these years
Just a question?? Who here thinks if Advaxis presents PSA data at ASCO. If it will be combo data with Keytruda or just the Advaxis arm data alone.
Take a look at Aduro’s financials and then you can tell what a piss poor job our management and BOD have done. Our deals have been junk. Even the Amgen deal was weak compared to the upfront payments these other bio’s bring in and that will tell you why we are where we are today
IR could not confirm that the offering has been completed
Gold, thanks for all the links to these articles. Nice to see that they are getting the word out. It would just be nice to see this company with so much potential finally rise. Hopes for good news in the a.m.
Lol, do you actually know how far away this milestone payment is. Year’s away!!!!
This is why everyone should be voting NO. I can’t understand for the life of me the investors that have voted yes and are okay with the position the company is in right now. It’s just crazy.
Better get a PR tomorrow that the offering has been completed or I smell trouble and that would verify that Noelle is a lair or the posters on this MB are liars
I believe that!!!! This is a steal, basically a crime at $2 a share. What is taking so LONG TO ANNOUNCE THE CLOSING. So we can hopefully start to try to move towards $3 again. FOR CRYING OUT LOUD
We won’t head north until they close this offering. If they had such great/big names involved. Why haven’t they announced the closing yet? Oh that’s right because it’s Advaxis we are talking about and everything is done extra slow or always delayed. This is just getting pathetic!!!
Don’t understand why the BMY phase 3 trial is still listed all over the slides. I thought we were not moving forward with that project anymore
Someone on this board posted that they confirmed that a poster was already submitted for ASCO. Not that it was accepted or that person was telling the truth but we know that this was Advaxis goal. To present Prostate data at a major medical meeting. Basically insinuating that data was good but I don’t trust anybody at the company anymore. They seem to be in damage control big time
Once again if the Advaxis/Merck combo data is so good to present at ASCO. Why not wait a few months to do the offering. Could all be signs of BS. Be prepared for another NEO delay with Amgen and that would be the nail in the coffin
This will end just like PETX offering. They will pull the offering after the pps gets hammered but it won’t matter because the damage will already have been done
Same place they have alway been. Somewhere with their heads stuck up their azz
12 mil at 2.25 or even 2.00 basically gets us 1qt of burn. WOW!!!! Great job
Wow this company is completely lost. They have no idea what they are doing
One can only hope!!!! That a deal was already in the works but was contingent on successful submission of MAA and that they are now just finishing up any loose ends before announcing. Otherwise we are or could be in big trouble here. The other thing to look for as a big sign in my eyes is a deal with Merck. If the Prostate combo results are actually worth anything. Then a deal should be struck before ASCO or they are most likely nothing to get excited about. Any more delays to Amgen trial and I would think they might walk away. Next 3-4 months are swim or sink for this bio.
I will wait a little longer before I vote but do remember that four BOD members received 6 million votes against them last year. So someone definitely wasn’t happy and I’m sure there a lot more unhappy folks this year. I can only hope these greedy BOD members finally get the boot. There is only one I believe I’ll be voting to keep but hopefully February ends with a bang
Was the corporate presentation ever updated today
Finally some good news this morning and who cares about ADXS-DAUL. I said it when they made the deal that it made absolutely no sense that we would agree to pay for a phase 3 trial with all the other expenses we had. It was downright foolish idea/deal but the only question that remains will somebody like Amgen setup and help us get to the finish line
So far looks like another wasted week and another day closer to end of Q1 with nothing but silence
How Disgusting!!!!!! Don’t worry though it’s only manipulation at its best, lol It has nothing to do with the lack of any meaningful updates or the fact that everything was delayed for WHAT REASON. Wake up people!!! Enough is enough!!! Everyone should be voting NO and we can only hope we have some Tutes voting NO as well
Could you please release some real news today or at least sometime this week, for crying out loud!!!!!
Tell Noelle.... that the shareholders meeting isn’t until March 21st. Which is basically the end of Q1. I for one am sick of hearing about all these milestones. Shows us something before the shareholders meeting. EU filing, new CEO, new CMO. Something for crying out loud!!!!! SHOW ME THE MONEY
Question?? So in the CC in December Tony said that they didn’t file the EMA because the agency was either closed or not taking applications that month but made it sound like Advaxis was ready. So I don’t know what would be the reason that they didn’t file this January. Also they talked about how the search for a CMO and sounded like they were close but yet again January 18 is gone and nothing. Here is to hoping February is full of news!!!!!
Hopefully we can keep the PR machine rolling this week
Amen!!!! Vote NO until they deliver something of substance.
As of right now I’m a definite NO on everything!!! Like you said, enough is enough already unless they surprise us with some really good news in the next few weeks